|
Journal of Bone and Joint Surgery - British Volume, Vol 90-B, Issue 1,
27-30.
doi: 10.1302/0301-620X.90B1.19731 Copyright © 2008 by British Editorial Society of Bone and Joint Surgery Long-term results of a hydroxyapatite-coated femoral component in total hip replacementA 15- TO 21-YEAR FOLLOW-UP STUDYS. S. Rajaratnam, FRCS (Tr & Orth), BSc (Hons), Senior Hip & Knee Fellow1; C. Jack, MRCS, Specialist Registrar2; A. Tavakkolizadeh, FRCS (Tr & Ortho), MSc, Specialist Registrar3; M. D. George, FRCS (Tr & Orth), Hip Fellow4; R. J. Fletcher, MRCS, BSc(Hons), Research Registrar5; M. Hankins, BSc(Hons), FRSS, Senior Research Fellow/Statistician6; and J. A. N. Shepperd, FRCS, Consultant Orthopaedic Surgeon5
1 Peninsula Orthopaedic Research Institute, 812 Pittwater Road, Deewhy, Sydney, Australia. Correspondence should be sent to Mr S. S. Rajaratnam; e-mail: srajaratnam{at}talk21.com
Between 1986 and 1991 we implanted 331 consecutive Furlong hydroxyapatite-coated femoral components of a total hip replacement in 291 patients. A cemented acetabular prosthesis was used in 217 hips and a hydroxyapatite-coated component in 114. We describe the long-term clinical and radiological survival of the femoral component at a mean follow-up of 17.5 years (15 to 21). Only two patients (0.68%) were lost to follow-up. With revision of the femoral component for any reason as the endpoint, the survival at a mean of 17 years was 97.4% (95% confidence interval 94.1 to 99.5), and with revision for aseptic loosening as the endpoint it was 100%. The survival at a maximum of 21 years with revision of the femoral component for any reason as the endpoint was 97.4% (95% confidence interval 81.0 or 99.5). These results compare favourably with the best long-term results of cemented or uncemented femoral components used in total hip replacement. This article has been cited by other articles:
|
|
||||||||||||



